SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-20-000050
Filing Date
2020-08-13
Accepted
2020-08-13 16:49:13
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx10-q2020x06.htm 10-Q 1091358
2 DESCRIPTION OF THE REGISTRANT'S SECURITIES exhibit44.htm EX-4.4 46126
3 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit311.htm EX-31.1 9959
4 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit312.htm EX-31.2 9928
5 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit321.htm EX-32.1 7258
6 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit322.htm EX-32.2 7248
  Complete submission text file 0001610618-20-000050.txt   4767437

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cdtx-20200630.xml EX-101.INS 717629
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20200630.xsd EX-101.SCH 42854
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20200630_cal.xml EX-101.CAL 52051
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20200630_def.xml EX-101.DEF 203347
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20200630_lab.xml EX-101.LAB 537875
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20200630_pre.xml EX-101.PRE 316430
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 201099981
SIC: 2836 Biological Products, (No Diagnostic Substances)